TY - JOUR AU - Gleason, D. F. PY - 1966 DA - 1966// TI - Classification of prostatic carcinoma JO - Cancer Chemother Rep VL - 50 ID - Gleason1966 ER - TY - JOUR AU - Gleason, D. F. AU - Mellinger, G. T. PY - 1974 DA - 1974// TI - Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging JO - J Urol VL - 111 ID - Gleason1974 ER - TY - CHAP AU - Gleason, D. F. ED - Tannenbaum, M. PY - 1977 DA - 1977// TI - Histologic grading and clinical staging of prostatic carcinoma BT - Urologic Pathology: The Prostate PB - Lea and Febiger CY - Philadelphia ID - Gleason1977 ER - TY - BOOK PY - 2001 DA - 2001// TI - General rule for clinical and pathological studies on prostate cancer PB - Kanahara-Shuppan CY - Tokyo ID - ref4 ER - TY - STD TI - Oesterling JE, Brendler CB, Epstein JI, Kimball AW Jr, Walsh PC. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol. 1987;38:92. ID - ref5 ER - TY - JOUR AU - Epstein, J. I. AU - Pizov, G. AU - Walsh, P. C. PY - 1993 DA - 1993// TI - Correlation of pathologic findings with progression after radical retropubic prostatectomy JO - Cancer VL - 71 UR - https://doi.org/3.0.CO;2-Y DO - 3.0.CO;2-Y ID - Epstein1993 ER - TY - STD TI - Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001;58:843. ID - ref7 ER - TY - STD TI - Allsbrook WC Jr, Mangold KA, Johnson MH, Lane RB, Lane CG, Amin MB et al. Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol. 2001;32:74. ID - ref8 ER - TY - STD TI - McLean M, Srigley J, Banerjee D, Warde P, Hao Y. Interobserver variation in prostate cancer Gleason scoring: are there implications for the design of clinical trials and treatment strategies? Clin Oncol (R Coll Radiol). 1997;9:222. ID - ref9 ER - TY - JOUR AU - Coard, K. C. AU - Freeman, V. L. PY - 2004 DA - 2004// TI - Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies JO - Am J Clin Patol VL - 122 UR - https://doi.org/10.1309/MHCY35FJ296CLLC8 DO - 10.1309/MHCY35FJ296CLLC8 ID - Coard2004 ER - TY - STD TI - Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL.The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228. ID - ref11 ER - TY - STD TI - Billis A, Quintal MM, Meirelles L, Freitas LL, Costa LB, Bonfitto JF, et al. The value of the 2005 International Society of Urological Pathology (ISUP) modified Gleason grading system as a predictor of biochemical recurrence after radical prostatectomy. Int Urol Nephrol. 2014;46:935. ID - ref12 ER - TY - STD TI - Dong F, Wang C, Farris AB, Wu S, Lee H, Olumi AF, et al.  Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system. Am J Surg Pathol. 2012;36:838. ID - ref13 ER - TY - STD TI - Ito K, Ohi M, Yamamoto T, Miyamoto S, Kurokawa K, Fukabori Y, et al.The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with proatate specific antigen levels of 4.1-10.0 ng/mL. Cancer. 2002;95:2112. ID - ref14 ER - TY - STD TI - Tanaka N1, Fujimoto K, Yoshikawa M, Tanaka M, Hirao Y, Kondo H, et al. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostatecancer. Hinyokika kiyo. 2007;53:459. ID - ref15 ER - TY - STD TI - Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003;169:517. ID - ref16 ER - TY - STD TI - Tanaka N, Fujimoto K, Hirayama A, Torimoto K, Okajima E, Tanaka M, et al. Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study. Int J Clin Oncol. 2011;16:553. ID - ref17 ER - TY - STD TI - Potters L, Purrazzella R, Brustein S, Fearn P, Huang D, Leibel SA, et al. The prognostic significance of Gleason grade in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Boil Phys. 2003;56:749. ID - ref18 ER - TY - STD TI - Sabolch A1, Feng FY, Daignault-Newton S, Halverson S, Blas K, Phelps L, et al. Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation. Int J Radiat Oncol Boil Phys. 2011;81:e351. ID - ref19 ER - TY - STD TI - Burchardt M, Engers R, Müller M, Burchardt T, Willers R, Epstein JI, et al. Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays. J cancer Res Clin Oncol. 2008;134:1071. ID - ref20 ER - TY - STD TI - King CR, McNeal JE, Gill H, Presti JC Jr. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys. 2004;59:386. ID - ref21 ER - TY - STD TI - Mikami Y, Manabe T, Epstein JI, Shiraishi T, Furusato M, Tsuzuki T, et al. Accuracy of Gleason grading by practicing pathologists and the impact of education on improving agreement. Hum Pathol. 2003;34:658. ID - ref22 ER - TY - STD TI - Egevad L. Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images. Urology. 2001;57:291. ID - ref23 ER - TY - STD TI - Barqawi AB, Turcanu R, Gamito EJ, Lucia SM, O'Donnell CI, Crawford ED, et al. The value of second-opinion pathology diagnosis on prostate biopsies from patients reffered for management of prostate cancer. Int J Clin Exp Pathol. 2011;4:468–75. ID - ref24 ER -